Fulvestrant plus capivasertib for metastatic breast cancer
Lancet Oncol
.
2020 May;21(5):e232.
doi: 10.1016/S1470-2045(20)30153-4.
Author
Tim Johannes Adrianus Dekker
1
Affiliation
1
Department of Internal Medicine, Haaglanden Medisch Centrum, The Hague 2512 VA, Netherlands. Electronic address: t.j.a.dekker@gmail.com.
PMID:
32359497
DOI:
10.1016/S1470-2045(20)30153-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Aromatase Inhibitors
Aromatase*
Estrogens
Fulvestrant*
Humans
Neoplasm Recurrence, Local
Substances
Aromatase Inhibitors
Estrogens
Fulvestrant
Aromatase